Literature DB >> 18586993

Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial.

Amy M Kilbourne1, Edward P Post, Agnes Nossek, Larry Drill, Susan Cooley, Mark S Bauer.   

Abstract

OBJECTIVES: Comorbid medical conditions, notably cardiovascular disease, occur disproportionately among persons with bipolar disorder; yet the quality and outcomes of medical care for these individuals are suboptimal. This pilot study examined a bipolar disorder medical care model (BCM) and determined whether, compared with usual care, individuals randomly assigned to receive BCM care had improved medical and psychiatric outcomes.
METHODS: Persons with bipolar disorder and cardiovascular disease-related risk factors were recruited from a large Department of Veterans Affairs mental health facility and randomly assigned to receive BCM or usual care. BCM care consisted of four self-management sessions on bipolar disorder symptom control strategies, education and behavioral change related to cardiovascular disease risk factors, and promotion of provider engagement. Primary outcomes were physical and mental health-related quality of life; secondary outcomes included functioning and bipolar symptoms.
RESULTS: Fifty-eight persons participated. Twenty-seven received BCM care, and 31 received usual care. The mean+/-SD age was 55+/-8 years, 9% were female, 90% were white, and 10% were African American. Repeated-measures analysis was used, and significant differences were observed between the two groups in change in scores from baseline to six months for the 12-Item Short-Form Health Survey (SF-12) subscale for physical health (t=2.01, df=173, p=.04), indicating that the usual care group experienced a decline in physical health over the study period. Change in SF-12 scores also indicated that compared with the usual care group, the BCM group showed improvements in mental health-related quality of life over the six-month study period; however, this finding was not significant.
CONCLUSIONS: Compared with usual care, BCM care may have slowed the decline in physical health-related quality of life. Further studies are needed to determine whether BCM care leads to long-term positive changes in physical and mental health-related quality of life and reduced risk of cardiovascular disease among persons with bipolar disorder.

Entities:  

Mesh:

Year:  2008        PMID: 18586993     DOI: 10.1176/ps.2008.59.7.760

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  41 in total

1.  Change in Patient Outcomes After Augmenting a Low-level Implementation Strategy in Community Practices That Are Slow to Adopt a Collaborative Chronic Care Model: A Cluster Randomized Implementation Trial.

Authors:  Shawna N Smith; Daniel Almirall; Katherine Prenovost; Celeste Liebrecht; Julia Kyle; Daniel Eisenberg; Mark S Bauer; Amy M Kilbourne
Journal:  Med Care       Date:  2019-07       Impact factor: 2.983

2.  High Prevalence of Metabolic Syndrome Among Adolescents and Young Adults With Bipolar Disorder.

Authors:  Christine Li; Boris Birmaher; Brian Rooks; Mary Kay Gill; Heather Hower; David A Axelson; Daniel P Dickstein; Tina R Goldstein; Fangzi Liao; Shirley Yen; Jeffrey Hunt; Satish Iyengar; Neal D Ryan; Michael A Strober; Martin B Keller; Benjamin I Goldstein
Journal:  J Clin Psychiatry       Date:  2019-07-30       Impact factor: 4.384

3.  Enhanced fidelity to treatment for bipolar disorder: results from a randomized controlled implementation trial.

Authors:  Jeanette Waxmonsky; Amy M Kilbourne; David E Goodrich; Kristina M Nord; Zongshan Lai; Christina Laird; Julia Clogston; Hyungjin Myra Kim; Christopher Miller; Mark S Bauer
Journal:  Psychiatr Serv       Date:  2014-01-01       Impact factor: 3.084

Review 4.  A systematic review of self-management health care models for individuals with serious mental illnesses.

Authors:  Erin L Kelly; Karissa M Fenwick; Nicholas Barr; Heather Cohen; John S Brekke
Journal:  Psychiatr Serv       Date:  2014-10-31       Impact factor: 3.084

Review 5.  Integrating bipolar disorder management in primary care.

Authors:  Amy M Kilbourne; David E Goodrich; Allison N O'Donnell; Christopher J Miller
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

6.  Long-Term Clinical Outcomes from a Randomized Controlled Trial of Two Implementation Strategies to Promote Collaborative Care Attendance in Community Practices.

Authors:  Amy M Kilbourne; David E Goodrich; Kristina M Nord; Celeste Van Poppelen; Julia Kyle; Mark S Bauer; Jeanette A Waxmonsky; Zongshan Lai; Hyungjin M Kim; Daniel Eisenberg; Marshall R Thomas
Journal:  Adm Policy Ment Health       Date:  2015-09

7.  Development and validation of the ASPIRE-VA coaching fidelity checklist (ACFC): a tool to help ensure delivery of high-quality weight management interventions.

Authors:  Laura J Damschroder; David E Goodrich; Hyungjin Myra Kim; Robert Holleman; Leah Gillon; Susan Kirsh; Caroline R Richardson; Lesley D Lutes
Journal:  Transl Behav Med       Date:  2016-09       Impact factor: 3.046

8.  A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study.

Authors:  Benjamin G Druss; Silke A von Esenwein; Michael T Compton; Kimberly J Rask; Liping Zhao; Ruth M Parker
Journal:  Am J Psychiatry       Date:  2009-12-15       Impact factor: 18.112

9.  Clinical and demographic factors associated with homelessness and incarceration among VA patients with bipolar disorder.

Authors:  Laurel A Copeland; Alexander L Miller; Deborah E Welsh; John F McCarthy; John E Zeber; Amy M Kilbourne
Journal:  Am J Public Health       Date:  2009-03-19       Impact factor: 9.308

10.  Mental health treatment preferences and challenges of living with multimorbidity from the veteran perspective.

Authors:  Elizabeth A DiNapoli; Christopher Cinna; Karen L Whiteman; Lauren Fox; Cathleen J Appelt; John Kasckow
Journal:  Int J Geriatr Psychiatry       Date:  2016-07-21       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.